A detailed history of Gamma Investing LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 433 shares of VCYT stock, worth $18,147. This represents 0.0% of its overall portfolio holdings.

Number of Shares
433
Previous 279 55.2%
Holding current value
$18,147
Previous $9.5 Million 80.55%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 02, 2025

BUY
$31.92 - $44.4 $4,915 - $6,837
154 Added 55.2%
433 $17.1 Million
Q3 2024

Oct 04, 2024

BUY
$21.0 - $35.25 $4,179 - $7,014
199 Added 248.75%
279 $9.5 Million
Q2 2024

Jul 02, 2024

SELL
$18.86 - $23.55 $735 - $918
-39 Reduced 32.77%
80 $1.73 Million
Q1 2024

Apr 05, 2024

BUY
$21.0 - $29.1 $1,638 - $2,269
78 Added 190.24%
119 $2.64 Million
Q4 2023

Feb 01, 2024

BUY
$19.72 - $28.68 $808 - $1,175
41 New
41 $1.03 Million

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $3B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.